Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis

Condition tags

MeSH descriptors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (14)

• Buserelin acetate in the treatment of pelvic pain associated with minimal and mild endometriosis: a controlled study via openalex
• Dosage aspects of danazol therapy in endometriosis. via openalex
• Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectiveness via openalex
• Endometriosis: Complications of CO2-laser endoscopic excision of deep endometriosis via openalex
• Novel vaginal danazol ring therapy for pelvic endometriosis, in particular deeply infiltrating endometriosis via openalex
• Progestins for symptomatic endometriosis: a critical analysis of the evidence via openalex
• Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device via openalex
• Treatment of Endometriosis with Estrogen-Progestin Combination and Progestogens Alone via openalex
• W2477008945 via openalex
• W1976837122 via openalex
• W1994486622 via openalex
• W2002100432 via openalex
• W2093175079 via openalex
• W327937967 via openalex

Cited by (50)

• Deep endometriosis demystified: Natural progression, hormonal treatment, and malignant transformation 2025
• Comprehensive endometriosis care: a modern multimodal approach for the treatment of pelvic pain and endometriosis 2024
• Levonorgestrel intrauterine system versus dienogest effect on quality of life of women with deep endometriosis: a randomized open-label clinical trial 2024
• Tolerability of endometriosis medical treatment: a comparison between combined hormonal contraceptives and progestins 2023
• Targeting c-MYC: a potential non-hormonal therapeutic approach for endometriosis treatment 2023
• Robotic-assisted versus conventional laparoscopic approach in patients with large rectal endometriotic nodule: the evaluation of safety and complications 2023
• Tolerability of endometriosis medical treatment: a comparison between combined hormonal contraceptives and progestins 2023
• The laterality of endometriosis 2023
• Clinical and sonographic impact of oral contraception in patients with deep endometriosis and adenomyosis at 2 years of follow-up 2023
• Endometriosis del tabique rectovaginal 2023
• Eficácia do sistema liberador de levonorgestrel no tratamento da dor pélvica crônica associada a endometriose / Efficacy of levonorgestrel-releasing system in the treatment of chronic pelvic pain associated with endometriosis 2022
• Medical treatments of endometriosis: a review 2022
• AVALIAÇÃO DE BIOMARCADORES EM MULHERES COM ENDOMETRIOSE E DOR USUÁRIAS DO IMPLANTE COM ETONOGESTREL OU SISTEMA INTRAUTERINO COM LEVONORGESTREL: ENSAIO CLÍNICO RANDOMIZADO 2022
• Avaliação de dois biomarcadores e de escores de dor pélvica crônica associada à endometriose em usuárias do implante com etonogestrel e do sistema intrauterino com levonorgestrel de 52 mg por 24 meses; e avaliação das vivências dos parceiros destas mulheres após o tratamento 2022
• Specifics of prescribing menopausal hormonal therapy in patients with the anamnestic endometriosis 2021
• General practitioners and endometriosis: Level of knowledge and the impact of training 2021
• Endometriose Aspectos clínicos do diagnóstico ao tratamento 2021
• Evolution of Bowel Complaints after Laparoscopic Endometriosis Surgery: A 1497 Women Comparative Study 2021
• Progestogens and Endometriosis 2021
• Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery 2021
• Endometriosis 2021
• Endometriosis-associated pain scores and biomarkers in users of the etonogestrel-releasing subdermal implant or the 52-mg levonorgestrel-releasing intrauterine system for up to 24 months 2020
• Contraceptive Use of Levonorgestrel Intrauterine System: Case Series 2020
• Hormonal Treatment of Bowel Endometriosis 2020
• The Etonogestrel Contraceptive Implant as a Therapy for Endometriosis 2020
• Endometriosis Pain Management: a Review 2020
• <p>Bowel Endometriosis: Current Perspectives on Diagnosis and Treatment</p> 2020
• Medical treatment of endometriosis: is it a choice of the physician? 2020
• Chapitre 3 : Prise en charge médicale de la douleur associée à l'endométriose 2019
• Hormonal contraception in women with endometriosis: a systematic review 2019
• Medical management of deeply infiltrating endometriosis - 7 year experience in a tertiary endometriosis centre in London 2019
• Tratamientos farmacológicos de la endometriosis (a excepción de la adenomiosis) 2018
• Medical and Surgical Management of Endometriosis 2018
• Avaliação de biomarcadores em mulheres com endometriose e dor usuárias do implante liberador de etonogestrel ou sistema intrauterino liberador de levonorgestrel = Assessment of biomarkers among women with endometriosis-associated pain users of the etonogestrel-releasing contraceptive implant or 52-mg levonorgestrel releasing intrauterine system: randomized clinical trial 2018
• RETIRED: No. 164-Consensus Guidelines for the Management of Chronic Pelvic Pain 2018
• Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis 2018
• Future Directions in Endometriosis Research and Therapeutics 2018
• RETIRED: No 164 - Directive clinique de consensus pour la prise en charge de la douleur pelvienne chronique 2018
• The levonorgestrel‐releasing intrauterine system is associated with a reduction in dysmenorrhoea and dyspareunia, a decrease in <scp>CA</scp> 125 levels, and an increase in quality of life in women with suspected endometriosis 2018
• Signes spécifiques cliniques évocateurs de l’endométriose (hors adénomyose) et questionnaires de symptômes, de douleur et qualité de vie, RPC Endométriose CNGOF-HAS 2018
• Surgery using plasma energy for deep endometriosis: A quality of life assessment 2018
• Traitement médical de l’endométriose : prise en charge de la douleur et de l’évolution des lésions par traitement hormonal. RPC Endométriose CNGOF-HAS 2018
• Evaluation of sexual function in women with deep infiltrating endometriosis 2018
• Current and Emerging Therapeutics for the Management of Endometriosis 2018
• Medical treatment of endometriosis: an update 2017
• Endometriosis after menopause: physiopathology and management of an uncommon condition 2017
• A self-administered questionnaire to measure the painful symptoms of endometriosis: Results of a modified DELPHI survey of patients and physicians 2017
• Reevaluating response and failure of medical treatment of endometriosis: a systematic review 2017
• Role of medical therapy in the management of deep rectovaginal endometriosis 2017
• Endometriose — ein Überblick 2017

Source provenance

europepmc

last seen: 2026-06-11T06:19:48.454388+00:00

openalex

last seen: 2026-06-10T17:14:06.276822+00:00

pubmed

last seen: 2026-05-13T22:13:30.513821+00:00